The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Senderowicz Adrian since 2018.
This trader's CIK number is 1616230.
At the time of last reporting, Senderowicz Adrian was the Director of Puma Biotechnology, Inc.. (stock ticker symbol PBYI).
Also see all insider trading activities at Puma Biotechnology, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | CNST | 0 | $0 | 9,357 | $469,487 | 9,357 | $51,557 |
| 2019 | CNST | 0 | $0 | 27,232 | $751,902 | 27,232 | $150,048 |
| 2018 | CNST | 0 | $0 | 0 | $0 | 15,884 | $87,520 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | PBYI | 0 | $0 | 27,000 | $91,800 | 0 | $0 |
| 2024 | PBYI | 0 | $0 | 27,000 | $89,829 | 0 | $0 |
| 2023 | PBYI | 0 | $0 | 27,000 | $93,285 | 0 | $0 |
| 2022 | PBYI | 0 | $0 | 27,858 | $73,294 | 0 | $0 |
| 2021 | PBYI | 0 | $0 | 40,993 | $457,768 | 0 | $0 |
| 2020 | PBYI | 0 | $0 | 10,000 | $98,880 | 0 | $0 |
1. Constellation Pharmaceuticals Inc (CNST)
2. Puma Biotechnology, Inc. (PBYI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-05-12 | CNST | Option Ex | 9,357 | 5.51 | 51,557 |
| 2020-05-12 | CNST | Sale | 9,357 | 50.17 | 469,487 |
| 2019-11-06 | CNST | Option Ex | 27,232 | 5.51 | 150,048 |
| 2019-11-06 | CNST | Sale | 27,232 | 27.61 | 751,902 |
| 2018-12-13 | CNST | Option Ex | 15,884 | 5.51 | 87,520 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-13 | PBYI | Sale | 27,000 | 3.40 | 91,800 |
| 2024-06-13 | PBYI | Sale | 27,000 | 3.33 | 89,829 |
| 2023-06-13 | PBYI | Sale | 27,000 | 3.46 | 93,285 |
| 2022-06-16 | PBYI | Sale | 27,858 | 2.63 | 73,294 |
| 2021-06-11 | PBYI | Sale | 40,993 | 11.17 | 457,768 |
| 2020-06-11 | PBYI | Sale | 10,000 | 9.89 | 98,880 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Senderowicz Adrian (Director of Puma Biotechnology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.